Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/new-prognostic-model-for-synchronous-metastatic-renal-cell-carcinoma-XWRtYeyOAx
References (24)
-
A. Bex, L. Albiges, B. Ljungberg, K. Bensalah, S. Dabestani, R. Giles, F. Hofmann, M. Hora, M. Kuczyk, T. Lam, L. Marconi, A. Merseburger, S. Fernandez-Pello, R. Tahbaz, Y. Abu-Ghanem, M. Staehler, A. Volpe, T. Powles (2018)
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma.European urology, 74 6
-
N. Shinohara, W. Obara, K. Tatsugami, S. Naito, T. Kamba, Masayuki Takahashi, S. Murai, T. Abe, K. Oba, S. Naito (2015)
Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapyCancer Science, 106
-
D. Orrell (1971)
Albumin as an aid to the interpretation of serum calcium.Clinica chimica acta; international journal of clinical chemistry, 35 2
-
D. You, I. Jeong, Cheryn Song, Jae-Lyun Lee, B. Hong, J. Hong, H. Ahn, Choung-Soo Kim (2015)
Analysis of pre-operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy era.Japanese journal of clinical oncology, 45 1
-
T. Choueiri, W. Xie, C. Kollmannsberger, S. North, J. Knox, J. Lampard, D. McDermott, B. Rini, D. Heng (2011)
The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.The Journal of urology, 185 1
-
A. Bex, P. Mulders, M. Jewett, J. Wagstaff, J. Thienen, C. Blank, R.C.E. Velthoven, M. Laguna, L. Wood, H. Melick, M. Aarts, J. Lattouf, T. Powles, I. Jong, S. Rottey, B. Tombal, S. Marréaud, S. Collette, L. Collette, J. Haanen (2019)
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical TrialJAMA Oncology, 5
-
A. Méjean, A. Ravaud, S. Thézénas, Sandra Colas, J. Beauval, K. Bensalah, L. Geoffrois, A. Thiery-Vuillemin, L. Cormier, H. Lang, L. Guy, G. Gravis, F. Rolland, C. Linassier, É. Lechevallier, C. Beisland, M. Aitchison, S. Oudard, J. Patard, C. Théodore, C. Chevreau, B. Laguerre, J. Hubert, M. Gross‐Goupil, J. Bernhard, L. Albiges, M. Timsit, T. Lebret, B. Escudier (2018)
Sunitinib Alone or after Nephrectomy in Metastatic Renal‐Cell CarcinomaThe New England Journal of Medicine, 379
-
S. Conti, I. Thomas, J. Hagedorn, B. Chung, G. Chertow, T. Wagner, J. Brooks, S. Srinivas, J. Leppert (2014)
Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy eraInternational Journal of Cancer, 134
-
D. Heng, W. Xie, M. Regan, M. Warren, A. Golshayan, C. Sahi, B. Eigl, J. Ruether, T. Cheng, S. North, P. Venner, J. Knox, K. Chi, C. Kollmannsberger, D. McDermott, W. Oh, M. Atkins, R. Bukowski, B. Rini, T. Choueiri (2009)
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 34
-
E. Steyerberg, M. Eijkemans, F. Harrell, J. Habbema (2001)
Prognostic Modeling with Logistic Regression AnalysisMedical Decision Making, 21
-
K. Gupta, Jeffrey Miller, Jim Li, M. Russell, C. Charbonneau (2008)
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review.Cancer treatment reviews, 34 3
-
EW Steyerberg, MJ Eijkemans, FE Harrell, JD Habbema (2001)
Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets, 21
-
D. Heng, J. Wells, B. Rini, B. Beuselinck, Jae-Lyun Lee, J. Knox, G. Bjarnason, S. Pal, C. Kollmannsberger, T. Yuasa, S. Srinivas, F. Donskov, A. Bamias, L. Wood, D. Ernst, N. Agarwal, U. Vaishampayan, S. Rha, Jenny Kim, T. Choueiri (2014)
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.European urology, 66 4
-
D. You, I. Jeong, J. Ahn, Dae-Ho Lee, Jae-Lyun Lee, J. Hong, H. Ahn, Choung-Soo Kim (2011)
The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.The Journal of urology, 185 1
-
D. Heng, W. Xie, M. Regan, L. Harshman, G. Bjarnason, U. Vaishampayan, M. Mackenzie, L. Wood, F. Donskov, M. Tan, S. Rha, N. Agarwal, C. Kollmannsberger, B. Rini, T. Choueiri (2013)
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study.The Lancet. Oncology, 14 2
-
K. Tatsugami, N. Shinohara, T. Kondo, Toshinari Yamasaki, M. Eto, T. Tsushima, T. Terachi, S. Naito (2015)
Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy eraInternational Journal of Urology, 22
-
N. Hanna, M. Sun, C. Meyer, P. Nguyen, S. Pal, Steven Chang, G. Velasco, Q. Trinh, T. Choueiri (2016)
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 27
-
Manish Patel, K. Beattie, A. Bang, H. Gurney, David Smith (2017)
Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survivalCancer Medicine, 6
-
S. Arora, A. Sood, D. Dalela, H. Tang, Amit Patel, J. Keeley, Q. Trinh, C. Rogers, M. Menon, F. Abdollah (2019)
Cytoreductive Nephrectomy: Assessing the Generalizability of the CARMENA Trial to Real-world National Cancer Data Base Cases.European urology, 75 2
-
T. Osawa, A. Takeuchi, T. Kojima, N. Shinohara, M. Eto, H. Nishiyama (2019)
Overview of current and future systemic therapy for metastatic renal cell carcinomaJapanese Journal of Clinical Oncology, 49
-
R. Motzer, N. Tannir, D. McDermott, O. Frontera, B. Melichar, T. Choueiri, E. Plimack, P. Barthélémy, C. Porta, S. George, T. Powles, F. Donskov, V. Neiman, C. Kollmannsberger, P. Salman, H. Gurney, R. Hawkins, A. Ravaud, M. Grimm, S. Bracarda, C. Barrios, Y. Tomita, D. Castellano, B. Rini, Allen Chen, S. Mekan, B. McHenry, M. Wind-Rotolo, J. Doan, P. Sharma, H. Hammers, B. Escudier (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal‐Cell CarcinomaThe New England Journal of Medicine, 378
-
R. Motzer, K. Penkov, J. Haanen, B. Rini, L. Albiges, M. Campbell, B. Venugopal, C. Kollmannsberger, S. Négrier, M. Uemura, J. Lee, A. Vasiliev, W. Miller, H. Gurney, M. Schmidinger, J. Larkin, M. Atkins, J. Bedke, B. Alekseev, Jing Wang, M. Mariani, P. Robbins, A. Chudnovsky, C. Fowst, S. Hariharan, B. Huang, A. Pietro, T. Choueiri (2019)
Avelumab plus Axitinib versus Sunitinib for Advanced Renal‐Cell CarcinomaThe New England Journal of Medicine, 380
-
R. Motzer, J. Bacik, B. Murphy, P. Russo, M. Mazumdar (2002)
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 1
-
B. Rini, E. Plimack, V. Stus, R. Gafanov, R. Hawkins, D. Nosov, F. Pouliot, B. Alekseev, D. Soulières, B. Melichar, I. Vynnychenko, A. Kryzhanivska, I. Bondarenko, S. Azevedo, D. Borchiellini, C. Szczylik, M. Markus, R. McDermott, J. Bedke, S. Tartas, Yen‐Hwa Chang, S. Tamada, Q. Shou, R. Perini, Mei Chen, M. Atkins, T. Powles (2019)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal‐Cell CarcinomaThe New England Journal of Medicine, 380
- Publisher
- Wiley
- Copyright
- Copyright © 2020 The Japanese Urological Association
- ISSN
- 0919-8172
- eISSN
- 1442-2042
- DOI
- 10.1111/iju.14215
- Publisher site
- See Article on Publisher Site
Abstract
Journal
International Journal of Urology – Wiley
Published: May 1, 2020
Keywords: ; ; ; ; ; ;